Solid Biosciences Ownership | Who Owns Solid Biosciences?
Solid Biosciences Ownership Summary
0.82% insiders, and 99.18% retail investors. Parallel advisors is the largest institutional shareholder, holding 0% of SLDB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.14% of its assets in Solid Biosciences shares.
SLDB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Solid Biosciences | - | 0.82% | 99.18% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Parallel advisors | 7.00 | - | $40.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Parallel advisors | 7.00 | - | $40.00 |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parallel advisors | 7.00 | - | 1.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parallel advisors | 7.00 | - | 1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | - | 7 | - | - | - | - | -100.00% | - | - |
| Jun 30, 2024 | 1 | - | 7 | 16.67% | - | - | 1 | - | - | - |
| Mar 31, 2024 | 1 | - | 6 | - | - | - | - | - | - | - |
| Dec 31, 2023 | 1 | - | 6 | - | - | - | - | - | - | - |
| Sep 30, 2023 | 1 | -50.00% | 6 | -91.67% | - | 20725.00% | - | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 854.68K | 2.14% | - |
| iShares Russell 2000 ETF | 626.50K | 1.57% | -2.40K |
| Vanguard Institutional Extnd Mkt Idx Tr | 342.97K | 0.86% | - |
| Fidelity Small Cap Index | 233.67K | 0.58% | -167.00 |
| iShares Russell 2000 Value ETF | 211.26K | 0.53% | -5.92K |
| iShares Biotechnology ETF | 210.69K | 0.53% | -1.52K |
| CREF Stock R1 | 206.98K | 0.52% | 64.33K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 130.00K | 0.33% | -2.00K |
| Fidelity Extended Market Index | 116.10K | 0.29% | -765.00 |
| Vanguard Russell 2000 ETF | 107.34K | 0.27% | 1.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 28, 2025 | Ganot Ilan | - | Sell | $447.78 |
| Jan 10, 2025 | Tan Kevin | CFO & Treasurer | Sell | $15.85K |
| Jan 06, 2025 | Ganot Ilan | - | Sell | $4.55K |
| Dec 03, 2024 | Hanrahan Jessie | Chief Regulatory Officer | Sell | $25.82K |
| Dec 03, 2024 | Cumbo Alexander | President and CEO | Sell | $62.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | - |
| 2024 Q2 | 1 | 1 |
| 2024 Q1 | 2 | 3 |
| 2023 Q4 | - | 5 |
SLDB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools